Gallbladder actinomycosis: Is it a complication after radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Hyung Joon | - |
dc.contributor.author | Choi, Sae Byeol | - |
dc.contributor.author | Kim, Wan Bae | - |
dc.contributor.author | Song, Tae Jin | - |
dc.contributor.author | Choi, Sang Yong | - |
dc.date.accessioned | 2021-09-07T12:01:50Z | - |
dc.date.available | 2021-09-07T12:01:50Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011-06 | - |
dc.identifier.issn | 1895-1058 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/112337 | - |
dc.description.abstract | A 64-year-old man with a history of gallstones, common bile duct stones, chronic hepatitis B virus infection, and hepatic cirrhosis with a Child-Pugh score B was satisfactorily treated for hepatocellular carcinoma with radiofrequency ablation and transarterial chemoembolization. His course, however, was complicated by gallbladder actinomycosis 14 months after treatment, resulting in acute cholecystitis. Such a chain of events suggests that gallbladder actinomycosis may develop after radiofrequency ablation and transarterial chemoembolization in patients who are known to have gallstones and that asymptomatic gallstones should be treated before the application of nonsurgical, but invasive procedures for hepatocellular carcinoma. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | VERSITA | - |
dc.subject | IMMUNOCOMPROMISED PATIENT | - |
dc.title | Gallbladder actinomycosis: Is it a complication after radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma? | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Han, Hyung Joon | - |
dc.contributor.affiliatedAuthor | Choi, Sae Byeol | - |
dc.contributor.affiliatedAuthor | Kim, Wan Bae | - |
dc.contributor.affiliatedAuthor | Song, Tae Jin | - |
dc.contributor.affiliatedAuthor | Choi, Sang Yong | - |
dc.identifier.doi | 10.2478/s11536-011-0006-4 | - |
dc.identifier.scopusid | 2-s2.0-79957460697 | - |
dc.identifier.wosid | 000289298000009 | - |
dc.identifier.bibliographicCitation | CENTRAL EUROPEAN JOURNAL OF MEDICINE, v.6, no.3, pp.300 - 304 | - |
dc.relation.isPartOf | CENTRAL EUROPEAN JOURNAL OF MEDICINE | - |
dc.citation.title | CENTRAL EUROPEAN JOURNAL OF MEDICINE | - |
dc.citation.volume | 6 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 300 | - |
dc.citation.endPage | 304 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | IMMUNOCOMPROMISED PATIENT | - |
dc.subject.keywordAuthor | Actinomycosis | - |
dc.subject.keywordAuthor | Gallstone | - |
dc.subject.keywordAuthor | Hepatocellular carcinoma | - |
dc.subject.keywordAuthor | Chemoembolization | - |
dc.subject.keywordAuthor | Radiofrequency ablation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.